fingolimod hydrochloride has been researched along with Alpha Virus Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carissimo, G; Chan, YH; Chee, RS; Cheng, P; Goggi, JL; Hartimath, SV; Khanapur, S; Lum, FM; Ng, LFP; Rajarethinam, R; Ramasamy, B; Rénia, L; Robins, EG; Teo, TH; Torres-Ruesta, A; Yong, FF | 1 |
1 other study(ies) available for fingolimod hydrochloride and Alpha Virus Infections
| Article | Year |
|---|---|
Longitudinal [18F]FB-IL-2 PET Imaging to Assess the Immunopathogenicity of O'nyong-nyong Virus Infection.
Topics: Alphavirus Infections; Animals; CD4-Positive T-Lymphocytes; Disease Models, Animal; Drug Repositioning; Female; Fingolimod Hydrochloride; Humans; Immunocompetence; Longitudinal Studies; Male; Mice; Mice, Inbred C57BL; O'nyong-nyong Virus; Positron-Emission Tomography; Viremia | 2020 |